Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.34% |
| 2 | Technology | 16.84% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Industrials | 10.11% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
First Interstate BancSystem
FIBK
$3.75B
| $2.02M | ﹤0.01% |
67,798
-71,000
| -51% | -$2.5M |
|
2027
Farmers National Banc Corp
FMNB
$946M
| $2.02M | ﹤0.01% |
159,884
-30,400
| -16% | -$420K |
|
2028
Schwab Emerging Markets Equity ETF
SCHE
$12.6B
| $2.02M | ﹤0.01% |
82,400
+2,200
| +3% | +$54.5K |
|
2029
Grupo Aval
AVAL
$6.22B
| $2.01M | ﹤0.01% |
860,644
-199,528
| -19% | -$470K |
|
|
DOYU
2030
DouYu International Holdings
DOYU
$142M
| $2.01M | ﹤0.01% |
169,068
+3,110
| +2% | +$46.1K |
|
2031
Transcat
TRNS
$838M
| $2.01M | ﹤0.01% |
22,500
+15,700
| +231% | +$1.34M |
|
2032
Weatherford International
WFRD
$6.33B
| $2M | ﹤0.01% |
+33,700
| New | +$1.97M |
|
2033
Legend Biotech
LEGN
$3.68B
| $1.99M | ﹤0.01% |
41,300
+10,400
| +34% | +$509K |
|
|
RAPT
2034
DELISTED
RAPT Therapeutics
RAPT
| $1.99M | ﹤0.01% |
13,563
+9,525
| +236% | +$1.93M |
|
2035
Burford Capital
BUR
$931M
| $1.99M | ﹤0.01% |
179,600
+38,800
| +28% | +$322K |
|
2036
Transact Technologies
TACT
$56.2M
| $1.98M | ﹤0.01% |
320,237
-4,100
| -1% | -$28.4K |
|
2037
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.39B
| $1.98M | ﹤0.01% |
103,300
+51,600
| +100% | +$994K |
|
|
TWOU
2038
DELISTED
2U Inc
TWOU
| $1.97M | ﹤0.01% |
9,604
-3
| -0% | -$750 |
|
2039
Distribution Solutions Group
DSGR
$1.6B
| $1.96M | ﹤0.01% |
86,400
-60,600
| -41% | -$1.27M |
|
2040
Oric Pharmaceuticals
ORIC
$1.1B
| $1.96M | ﹤0.01% |
344,100
+27,300
| +9% | +$143K |
|
2041
Relay Therapeutics
RLAY
$4.09B
| $1.96M | ﹤0.01% |
118,854
+58,054
| +95% | +$1.04M |
|
|
SHOE
2042
Shoe Station Group
SHOE
$419M
| $1.95M | ﹤0.01% |
+76,068
| New | +$1.98M |
|
2043
CEVA Inc
CEVA
$927M
| $1.95M | ﹤0.01% |
64,000
+15,600
| +32% | +$489K |
|
2044
Ranger Energy Services
RNGR
$379M
| $1.95M | ﹤0.01% |
191,048
+31,115
| +19% | +$339K |
|
2045
Ocugen
OCGN
$424M
| $1.95M | ﹤0.01% |
2,281,548
+858,692
| +60% | +$936K |
|
|
IBTX
2046
DELISTED
Independent Bank Group, Inc.
IBTX
| $1.94M | ﹤0.01% |
41,943
-3,600
| -8% | -$205K |
|
2047
HUTCHMED
HCM
$2.01B
| $1.94M | ﹤0.01% |
149,252
+59,700
| +67% | +$978K |
|
|
PPIH
2048
Perma-Pipe International
PPIH
$200M
| $1.94M | ﹤0.01% |
181,793
+1,495
| +0.8% | +$15.5K |
|
2049
Rocket Pharmaceuticals
RCKT
$372M
| $1.94M | ﹤0.01% |
113,374
-45,426
| -29% | -$889K |
|
2050
AmeriServ Financial
ASRV
$78.5M
| $1.94M | ﹤0.01% |
636,404
-11,147
| -2% | -$43K |
|
Similar funds
Renaissance Technologies's Q1 2023 Portfolio in Review
As of Q1 2023, Renaissance Technologies held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Renaissance Technologies added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Renaissance Technologies's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Renaissance Technologies fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Renaissance Technologies opened 524 new positions and closed 668 in Q1 2023.
- Renaissance Technologies's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.